Hideko Ohama Selected Research

Hideko Ohama Research Topics

Disease

34	Hepatocellular Carcinoma (Hepatoma) 10/2022 - 01/2013
11	Neoplasms (Cancer) 01/2022 - 09/2013
6	Ascites 05/2022 - 01/2020
5	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2020
5	Non-alcoholic Fatty Liver Disease 01/2021 - 01/2014
4	Fatigue 06/2022 - 01/2014
4	Liver Diseases (Liver Disease) 09/2021 - 01/2020
3	Carcinoma (Carcinomatosis) 09/2022 - 09/2013
3	Liver Neoplasms (Liver Cancer) 08/2021 - 01/2021
3	Hemorrhage 06/2021 - 02/2021
2	Edema (Dropsy) 05/2022 - 01/2014
2	Hypertension (High Blood Pressure) 03/2022 - 01/2022
2	Liver Failure 02/2021 - 01/2020
2	Infections 01/2020 - 02/2015
2	Fibrosis (Cirrhosis) 01/2020 - 01/2018
1	Hypothyroidism 06/2022
1	Diarrhea 06/2022
1	Hypertrophy 12/2021
1	Alcoholic Liver Diseases (Alcoholic Liver Disease) 09/2021
1	Fatty Liver 09/2021
1	Liver Cirrhosis (Hepatic Cirrhosis) 09/2021
1	Dysbiosis 09/2021
1	Autoimmune Diseases (Autoimmune Disease) 09/2021
1	Hepatitis 09/2021
1	Sarcopenia 07/2021
1	Disease Progression 07/2021
1	Thrombosis (Thrombus) 02/2021
1	Alcoholic Fatty Liver 01/2021
1	Sepsis (Septicemia) 01/2021
1	Pleural Effusion (Pleural Effusions) 01/2020
1	Surgical Wound Infection 01/2020
1	Diabetes Mellitus 01/2020
1	Respiratory Insufficiency (Respiratory Failure) 01/2019
1	Vomiting 11/2017
1	Nausea 11/2017
1	Insulin Resistance 04/2017
1	Necrosis 11/2016
1	Carcinogenesis 11/2016
1	Autoimmune Hepatitis 01/2016
1	Opportunistic Infections (Opportunistic Infection) 02/2015
1	Pneumonia (Pneumonitis) 02/2015

Drug/Important Bio-Agent (IBA)

15	lenvatinibIBA 06/2022 - 01/2020
8	atezolizumabIBA 10/2022 - 01/2022
8	Bevacizumab (Avastin)FDA Link 10/2022 - 01/2022
5	AlbuminsIBA 01/2022 - 01/2021
4	C-Reactive ProteinIBA 10/2022 - 09/2021
4	Proteins (Proteins, Gene)FDA Link 05/2022 - 12/2021
4	BilirubinIBA 01/2022 - 01/2021
3	alpha-Fetoproteins (alpha-Fetoprotein)IBA 10/2022 - 04/2021
3	Pharmaceutical PreparationsIBA 06/2021 - 11/2016
2	Serum AlbuminIBA 09/2021 - 08/2021
2	Immune Checkpoint InhibitorsIBA 01/2021 - 01/2020
1	Urea (Carbamide)FDA LinkGeneric 05/2022
1	Glucose (Dextrose)FDA LinkGeneric 12/2021
1	Insulin (Novolin)FDA Link 12/2021
1	GlycogenIBA 12/2021
1	Nonesterified Fatty Acids (NEFA)IBA 12/2021
1	PrebioticsIBA 09/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 09/2021
1	regorafenibIBA 08/2021
1	Sorafenib (BAY 43-9006)FDA Link 08/2021
1	RamucirumabIBA 04/2021
1	Fetal Proteins (Fetoprotein)IBA 01/2021
1	NivolumabIBA 01/2020
1	Indicators and Reagents (Reagents)IBA 01/2020
1	hydroxide ionIBA 01/2020
1	Alanine Transaminase (SGPT)IBA 01/2020
1	LigandsIBA 01/2020
1	AntibodiesIBA 01/2020
1	pembrolizumabIBA 01/2020
1	Ethanol (Ethyl Alcohol)IBA 01/2018
1	AntiemeticsIBA 11/2017
1	Cisplatin (Platino)FDA LinkGeneric 11/2017
1	3- (4- (4- (3- methyl- 1- phenyl- 1H- pyrazol- 5- yl)piperazin- 1- yl)pyrrolidin- 2- ylcarbonyl)thiazolidineIBA 04/2017
1	Rosuvastatin Calcium (Crestor)FDA Link 11/2016
1	CytokinesIBA 11/2016
1	Prednisolone (Predate)FDA LinkGeneric 01/2016
1	sairei-toIBA 01/2016
1	Transaminases (Aminotransferases)IBA 01/2016
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2016
1	Sitagliptin Phosphate (Januvia)FDA Link 11/2015
1	Malonyl Coenzyme A (Malonyl CoA)IBA 11/2015
1	Fatty Acids (Saturated Fatty Acids)IBA 11/2015
1	CarbohydratesIBA 11/2015
1	OligodeoxyribonucleotidesIBA 02/2015
1	Interleukin-12 (IL 12)IBA 02/2015
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 02/2015
1	Carnitine (L-Carnitine)FDA LinkGeneric 01/2015
1	diethylenetriamineIBA 06/2014
1	GadoliniumIBA 06/2014

Therapy/Procedure

10	Therapeutics 06/2022 - 01/2014
7	Hepatectomy 06/2022 - 01/2020
5	Radiofrequency Ablation 06/2021 - 01/2013
2	Drug Therapy (Chemotherapy) 01/2020 - 11/2017
1	Immunotherapy 10/2022
1	Fecal Microbiota Transplantation 09/2021
1	Blood Transfusion (Blood Transfusions) 02/2021
1	Radiotherapy 01/2021
1	Deep Sedation 01/2019
1	Ablation Techniques 01/2018